Replies to post #23715 on Amarantus Bioscience Holdings Inc (AMBS)

[cjstocksup]

LymPro has completed two human clinical studies to date, and is set to move immediately into the Phase 2 validation study required to begin generating revenue as a laboratory developed test (“LDT”) at an already-selected Certified Laboratory Improvement Amendments (“CLIA”) certified laboratory. Thereafter, we anticipate LymPro will begin its regulatory process with the Food and Drug Administration towards approval.


This one is even better!!!

FIRST TEST EVER FOR ALZHEIMERS DISEASE!!!
AMBS

[barbershop]

Alzheimer's Diagnostic Market estimated at $500MM Annually. What if AMBS can build out just 20% of that market? Monster opportunity here potentially for investors!

[smoke_em]

Also!!! the LymPro Alzheimer’s Diagnostic Blood Test option agreement

FIRST TEST EVER FOR ALZHEIMER'S DISEASE!!!


Working with JV!!

http://www.amarantus.com/wp-content/uploads/2012/10/121011-PR-AMBS-LymPro-FINAL.pdf